Skip to main content
Premium Trial:

Request an Annual Quote

ExonHit Gets $553K Grant for Participation in RESPONSIFY Project

NEW YORK (GenomeWeb News) – ExonHit today said that it will receive a €418,000 ($553,000) grant from the European Union for its participation in the recently announced RESPONSIFY consortium.

The Paris-based firm said that it will provide its Genome Wide SpliceArray platform for analysis of patient transcriptomic profiles. The company added that it will be in charge of filing for IP protection for relevant molecular signatures and associated tests and ensuring CE marking and commercialization of predictive tests identified on the platform.

The RESPONSIFY consortium was recently launched with the aim of developing tests to indicate how therapies will affect individual patients and enable doctors to make better decisions about whether to use neoadjuvant therapies or provide treatments after surgery. The partners intend to identify predictive biomarkers for response to two common chemotherapeutic treatments for breast cancer, Herceptin (trastuzumab) and Avastin (bevacizumab).

The three-year project will include partners in Belgium, France, Germany, Sweden, Switzerland, and the UK, and is being funded with approximately €6 million under the EU's 7th Framework Programme for Research and Technological Development.

"This grant, which covers more than 70 percent of our costs in this project, enables us to add predictive tests in a key indication to our existing development portfolio," Loic Maurel, president of Exonhit's management board, said in a statement.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.